Observational studyWorld journal of surgical oncology2025

Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis.

Yaohong Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.